3.1 Water Balance, Electrolytes, Osmolality, and Anion Gap Calculations

Water Balance, Electrolytes, Osmolality, and Anion Gap Calculations

Electrolyte homeostasis and water balance form the physiological cornerstone of cellular function, maintaining membrane potentials, enzymatic cofactors, and osmotic equilibrium across biological membranes. In the clinical chemistry laboratory, electrolyte profiling is among the most frequently ordered test batteries. Understanding the biochemical mechanisms, preanalytical pitfalls, analytical principles, and clinical interpretations of these analytes is essential for the medical technologist.

---

1. Fluid Compartments and Electrolyte Distribution

Total body water (TBW) accounts for approximately 60% of total body weight in an average adult male (50% in adult females due to higher percentage of adipose tissue, and up to 75-80% in neonates). Total body water is segregated into two primary anatomical compartments separated by semipermeable cell membranes:

1. Intracellular Fluid (ICF): Comprises approximately two-thirds (66%) of TBW. The predominant intracellular cation is potassium ($K^+$, $\approx 105-150\text{ mmol/L}$), supplemented by magnesium ($Mg^{2+}$, $\approx 15-30\text{ mmol/L}$). The predominant intracellular anions are organic phosphates (ATP, creatine phosphate) and proteins.
2. Extracellular Fluid (ECF): Comprises approximately one-third (33%) of TBW. The ECF is further subdivided into the interstitial fluid (surrounding cells, representing 75% of ECF) and the plasma/intravascular fluid (representing 25% of ECF). The predominant extracellular cation is sodium ($Na^+$, $135-145\text{ mmol/L}$), while the major extracellular anions are chloride ($Cl^-$, $98-107\text{ mmol/L}$) and bicarbonate ($HCO_3^-$, $22-29\text{ mmol/L}$).

This asymmetric distribution is actively sustained by the energy-consuming $Na^+/K^+$-ATPase membrane pump, which continuously extrudes three $Na^+$ ions from the cytoplasm into the ECF while pumping two $K^+$ ions from the ECF into the cell against steep electrochemical gradients. Failure of cell metabolism or ischemia causes the $Na^+/K^+$-ATPase pump to arrest, resulting in intracellular sodium and water accumulation (cellular swelling) and potassium leakage into the extracellular space.

---

2. Sodium Homeostasis ($Na^+$: 135–145 mmol/L)

Sodium is the principal extracellular cation and the primary osmotic contributor to ECF volume. The clinical regulation of sodium balance is tightly coupled to water regulation via three major neuroendocrine pathways:

• Renin-Angiotensin-Aldosterone System (RAAS): Triggered by decreased renal perfusion pressure detected by the juxtaglomerular apparatus, hyponatremia, or sympathetic stimulation. Renin cleaves angiotensinogen to angiotensin I, which is converted to angiotensin II by angiotensin-converting enzyme (ACE) in pulmonary endothelium. Angiotensin II triggers vasoconstriction and stimulates the adrenal cortex (zona glomerulosa) to secrete aldosterone. Aldosterone binds mineralocorticoid receptors in the distal convoluted tubules and cortical collecting ducts of the nephron, upregulating apical epithelial sodium channels (ENaC) and basolateral $Na^+/K^+$-ATPase pumps. This increases sodium and water reabsorption in exchange for potassium ($K^+$) and hydrogen ($H^+$) ion excretion.
• Atrial Natriuretic Peptide (ANP) and BNP: Released from atrial and ventricular myocytes in response to atrial stretch and volume expansion. ANP inhibits renin and aldosterone release, induces renal vasodilation, increases glomerular filtration rate (GFR), and promotes natriuresis (sodium excretion) and diuresis.
• Antidiuretic Hormone (ADH / Arginine Vasopressin): Synthesized in the supraoptic and paraventricular nuclei of the hypothalamus and stored in the posterior pituitary. Released in response to hypothalamic osmoreceptor stimulation (as little as a 1-2% increase in plasma osmolality) or baroreceptor detection of hypovolemia. ADH binds $V_2$ receptors on renal collecting ducts, mobilizing aquaporin-2 water channels to reabsorb free water without electrolytes.

Clinical Disorders of Sodium

Hyponatremia ($[Na^+] < 135\text{ mmol/L}$)

Hyponatremia is categorized according to measured serum osmolality and volume status:

• Hypertonic Hyponatremia (Hyperglycemic Pseudohyponatremia): Marked hyperglycemia draws intracellular water into the vascular space by osmosis, diluting extracellular sodium. For every $100\text{ mg/dL}$ rise in plasma glucose above normal ($100\text{ mg/dL}$), measured serum sodium drops by approximately $1.6\text{ mmol/L}$ (Katz formula) or $2.4\text{ mmol/L}$ (Hillier formula): $\text{Corrected } Na^+ = \text{Measured } Na^+ + 0.016 \times (\text{Glucose [mg/dL]} - 100)$
• Isotonic Hyponatremia (Pseudohyponatremia): Occurs with older indirect ion-selective electrode (ISE) potentiometry when the serum contains massive amounts of lipids (severe hypertriglyceridemia/chylomicronemia) or paraproteins (multiple myeloma). Plasma water fraction is normally 93% (7% solids). Extreme hyperlipidemia or hyperproteinemia expands the non-aqueous solid fraction (e.g., to 20%), causing an automated fixed-dilution step in indirect ISE analyzers to aspirate less true aqueous plasma water, falsely underestimating the true sodium concentration. Direct ISE (blood gas analyzers or point-of-care instruments) does not dilute the sample and provides the accurate electrolyte concentration.
• Hypotonic Hyponatremia: True hyponatremia, classified by extracellular volume status:
  • Hypovolemic: Loss of sodium and water, with sodium loss exceeding water loss. Causes include renal losses (diuretics, mineralocorticoid deficiency; urine $Na^+ > 20\text{ mmol/L}$) or extrarenal losses (severe vomiting, diarrhea, burns; urine $Na^+ < 20\text{ mmol/L}$).
  • Euvolemic: Normal total body sodium with moderate free water excess. The classic etiology is the Syndrome of Inappropriate ADH Secretion (SIADH), seen in small cell lung carcinoma, head trauma, and CNS infections, characterized by concentrated urine (urine osmolality $>100\text{ mOsm/kg}$, urine $Na^+ > 40\text{ mmol/L}$) despite serum hypoosmolality. Other causes include primary psychogenic polydipsia and severe hypothyroidism.
  • Hypervolemic: Increase in total body water greater than total body sodium, associated with edematous states such as congestive heart failure (CHF), hepatic cirrhosis, and nephrotic syndrome. Reduced effective circulating arterial volume triggers secondary hyperaldosteronism and non-osmotic ADH release.

Hypernatremia ($[Na^+] > 145\text{ mmol/L}$)

Hypernatremia always denotes hyperosmolality. Etiologies include:

• Hypovolemic: Pure water loss or hypotonic fluid loss exceeding sodium loss (severe dehydration, profuse diaphoresis, osmotic diuresis in diabetic ketoacidosis).
• Euvolemic: Diabetes Insipidus (DI), characterized by polyuria ($>3\text{ L/day}$) and polydipsia. Neurogenic (central) DI involves failure of hypothalamic-pituitary synthesis or release of ADH; Nephrogenic DI involves renal tubular unresponsiveness to circulating ADH (due to lithium toxicity, hypercalcemia, or congenital V2 receptor mutations). Water deprivation testing demonstrates inappropriately dilute urine (urine osmolality $<300\text{ mOsm/kg}$).
• Hypervolemic: Sodium gain exceeding water gain, typically iatrogenic (intravenous infusion of hypertonic 3% or 5% NaCl, hypertonic sodium bicarbonate) or primary hyperaldosteronism (Conn syndrome).

---

3. Potassium Dynamics and Preanalytical Artifacts ($K^+$: 3.5–5.0 mmol/L)

Potassium is the predominant intracellular cation ($\approx 150\text{ mmol/L}$ intracellular vs $3.5-5.0\text{ mmol/L}$ extracellular). The high intracellular-to-extracellular potassium ratio ($[K^+]_i / [K^+]_o$) is the critical physiological determinant of the resting membrane potential (RMP) of excitable tissues, as governed by the Nernst equation: $E_{\text{rev}} = \frac{RT}{zF} \ln \frac{[K^+]_o}{[K^+]_i}$

Clinical Pathologies

• Hypokalemia ($[K^+] < 3.5\text{ mmol/L}$): Increases resting membrane potential negativity (hyperpolarization), causing muscle weakness, hyporeflexia, paralysis, paralytic ileus, and fatal cardiac arrhythmias. Electrocardiogram (ECG) reveals flattened or inverted T waves, ST-segment depression, and prominent U waves.
  • Mechanisms: Gastrointestinal loss (vomiting, diarrhea), renal loss (loop or thiazide diuretics, hyperaldosteronism, Cushing syndrome, renal tubular acidosis), and transcellular shifting into cells (insulin administration, alkalemia, $\beta_2$-adrenergic agonist therapy).
• Hyperkalemia ($[K^+] > 5.0\text{ mmol/L}$): Decreases resting membrane potential (depolarization), leading to neuromuscular excitability followed by inactivation of sodium channels and muscle flaccidity. ECG abnormalities progress predictably: tall, peaked, symmetrical T waves $\rightarrow$ prolonged PR interval $\rightarrow$ flattening and loss of P waves $\rightarrow$ widening of QRS complex $\rightarrow$ sine wave configuration $\rightarrow$ ventricular fibrillation or asystole. Hyperkalemia is a critical medical emergency requiring rapid intervention with intravenous calcium gluconate (cardiac membrane stabilizer), insulin plus dextrose (transcellular shifting), and sodium polystyrene sulfonate or patiromer (potassium binders).
  • Mechanisms: Decreased renal excretion (acute or chronic kidney disease, Addison disease, potassium-sparing diuretics such as spironolactone, ACE inhibitors), transcellular shift out of cells (acidemia, insulin deficiency, massive tissue trauma, rhabdomyolysis, tumor lysis syndrome).

Critical Preanalytical Artifacts: Pseudohyperkalemia

Because potassium is concentrated 20- to 30-fold within cellular elements compared to plasma, preanalytical mishandling constitutes the most common cause of spurious hyperkalemia in clinical practice:

1. In Vitro Mechanical Hemolysis: Erythrocyte rupture releases massive amounts of intracellular potassium into serum or plasma. Each $100\text{ mg/dL}$ of free hemoglobin released in vitro raises measured potassium by roughly $0.3-0.4\text{ mmol/L}$, so a faintly pink specimen shows only a small rise, while gross hemolysis (dark red serum) can falsely elevate measured potassium by $2\text{ mmol/L}$ or more. Such specimens must be rejected and recollected.
2. Prolonged Tourniquet Application and Fist Clenching: Tourniquet application exceeding 60 seconds produces local venous stasis and hypoxia, causing cellular potassium efflux. Repetitive fist clenching ("pumping") during venipuncture causes forearm muscle contraction that releases intracellular potassium into regional venous blood, elevating serum potassium by up to $1.0-1.5\text{ mmol/L}$.
3. Extreme Thrombocytosis and Leukocytosis: In patients with marked thrombocytosis (platelet count $>1,000,000/\mu\text{L}$) or severe leukocytosis (white blood cell count $>100,000/\mu\text{L}$, as in acute or chronic leukemias), cells lyse or rupture during normal in vitro clot formation, releasing potassium into serum. To establish true in vivo potassium levels, blood must be collected in an anticoagulated tube (heparinized whole blood/plasma) and separated immediately without delay.
4. Delayed Centrifugation / Separation: If whole blood is allowed to sit uncentrifuged at room temperature for $>2$ hours, red cell glucose stores are depleted, glycolysis ceases, and ATP is exhausted. Without ATP, the $Na^+/K^+$-ATPase pump arrests, and intracellular potassium leaks into the serum. Conversely, refrigeration of uncentrifuged whole blood directly inactivates the $Na^+/K^+$-ATPase pump (which is temperature-dependent), driving severe potassium leakage into serum within 1-2 hours.
5. EDTA Tube Contamination: Drawing an EDTA tube ($K_2\text{EDTA}$ or $K_3\text{EDTA}$, purple top) prior to a serum (red/gold) or heparin (green) tube transfers potassium salts into the subsequent tube. This artifact is recognized by an impossible combination: extreme hyperkalemia ($>8-10\text{ mmol/L}$) accompanied by profound hypocalcemia ($<2-3\text{ mg/dL}$) and marked hypomagnesemia due to chelation of divalent cations by EDTA.

---

4. Chloride and Bicarbonate Dynamics

Chloride ($Cl^-$: 98–107 mmol/L)

Chloride is the major extracellular anion, providing electroneutrality and osmotic balance alongside sodium. Serum chloride concentrations generally track sodium fluctuations in parallel; when chloride diverges from sodium, it indicates a primary acid-base disturbance.

The Chloride Shift (Hamburger Phenomenon)

In peripheral tissue capillary beds, metabolically produced $CO_2$ diffuses into erythrocytes, where carbonic anhydrase hydrates it to carbonic acid ($H_2CO_3$), which rapidly dissociates into $H^+$ and $HCO_3^-$: $CO_2 + H_2O \xrightleftharpoons{\text{Carbonic Anhydrase}} H_2CO_3 \rightleftharpoons H^+ + HCO_3^-$ Intracellular deoxyhemoglobin buffers $H^+$. As the concentration of bicarbonate inside the erythrocyte rises, it exits the red cell down its concentration gradient into plasma via the anion exchanger 1 (AE1 / Band 3) protein. To maintain electrochemical neutrality across the erythrocyte membrane, extracellular chloride ($Cl^-$) moves into the red cell. In the pulmonary capillaries, the process reverses: chloride shifts back out into plasma as bicarbonate re-enters the red cell to be converted back into $CO_2$ and exhaled.

Sweat Chloride Testing in Cystic Fibrosis

Cystic Fibrosis (CF) is an autosomal recessive disorder caused by mutations in the CFTR (cystic fibrosis transmembrane conductance regulator) gene, which encodes a cyclic AMP-regulated epithelial chloride channel. In normal sweat gland ducts, CFTR reabsorbs chloride from primary sweat back into epithelial cells. In CF, defective CFTR impairs chloride reabsorption, producing abnormally salty sweat with elevated concentrations of chloride and sodium.

• Methodology (Gibson-Cooke Technique): Pilocarpine iontophoresis uses a low electric current to drive the cholinergic agent pilocarpine into localized forearm skin to stimulate localized sweating. Sweat is harvested onto weighed filter paper or collected via a capillary coil (Macroduct system) for a standardized collection period. Analysis is performed using coulometric-amperometric titration (chloridometer) or ion-selective electrodes.
• Diagnostic Criteria:
  • Normal: $\le 29\text{ mmol/L}$
  • Intermediate / Equivocal: $30-59\text{ mmol/L}$ (requires repeat testing and CFTR genetic testing)
  • Diagnostic of Cystic Fibrosis: $\ge 60\text{ mmol/L}$ (confirmed by repeating on a separate day or identifying two disease-causing CFTR mutations)

Bicarbonate ($HCO_3^-$: 22–29 mmol/L)

Bicarbonate is the second most abundant anion in the extracellular fluid and the physiological buffer maintaining blood pH at 7.40. In routine automated chemistry profiles, bicarbonate is measured as Total Carbon Dioxide ($tCO_2$): $\text{Total } CO_2 = [HCO_3^-] + [\text{dissolved } CO_2] + [H_2CO_3]$ Because dissolved $CO_2$ ($0.0307 \times pCO_2 \approx 1.2\text{ mmol/L}$) and carbonic acid ($H_2CO_3 \approx 0.0017\text{ mmol/L}$) comprise only a tiny fraction, $HCO_3^-$ constitutes $>95\%$ of measured total $CO_2$. Consequently, serum $tCO_2$ is clinically interchangeable with bicarbonate in non-critical metabolic acid-base assessment.

---

5. Anion Gap Calculations and Acidosis Differentiation

Electrochemical neutrality dictates that the total sum of positive charges in serum must exactly equal the total sum of negative charges. However, standard automated electrolyte panels measure only a subset of these ions ($Na^+$, $K^+$, $Cl^-$, $HCO_3^-$). The Anion Gap (AG) is a mathematical parameter representing the concentration of "unmeasured anions" (albumin, phosphate, sulfate, organic acids such as lactate and ketoacids) exceeding "unmeasured cations" ($Ca^{2+}$, $Mg^{2+}$, gamma-globulins).

Anion Gap Formulas and Reference Ranges

1. Standard Formula (Without Potassium): $\text{Anion Gap} = [Na^+] - ([Cl^-] + [HCO_3^-])$
   • Reference interval: $8 - 16\text{ mmol/L}$ (with older colorimetric methods; modern ion-selective electrode methodology often yields reference intervals of $7 - 14\text{ mmol/L}$).
2. Alternate Formula (With Potassium): $\text{Anion Gap} = ([Na^+] + [K^+]) - ([Cl^-] + [HCO_3^-])$
   • Reference interval: $10 - 20\text{ mmol/L}$.

Differential Diagnosis of Metabolic Acidosis

                               METABOLIC ACIDOSIS
                             (Low pH, Low HCO3-)
                                      |
                     Calculate Serum Anion Gap (AG)
                                      |
         +----------------------------+----------------------------+
         |                                                         |
   HIGH ANION GAP                                            NORMAL ANION GAP
   (AG > 16 mmol/L)                                          (AG 8-16 mmol/L)
   Unmeasured organic anions accumulate                      Hyperchloremic Acidosis
         |                                                         |
   M - Methanol                                              GI HCO3- Loss:
   U - Uremia (Renal Failure)                                - Diarrhea
   D - Diabetic Ketoacidosis                                 - Fistulas
   P - Paraldehyde / Propylene Glycol                              |
   I - Isoniazid / Iron                                      Renal Acidification Defect:
   L - Lactic Acidosis (Types A & B)                         - RTA Type 1 (Distal: impaired H+ excretion)
   E - Ethylene Glycol                                       - RTA Type 2 (Proximal: impaired HCO3- reabsorption)
   S - Salicylates                                           - RTA Type 4 (Hypoaldosteronism)

High Anion Gap Metabolic Acidosis (HAGMA)

Characterized by the consumption of $HCO_3^-$ by non-volatile, unmeasured organic acids. The negative charge of the conjugate base replaces bicarbonate, maintaining electroneutrality without altering chloride concentration. Classic etiologies are remembered by the mnemonic MUDPILES:

• M — Methanol: Toxic ingestion; metabolized by alcohol dehydrogenase to formaldehyde and formic acid (causes retinal toxicity, optic disc edema, and blindness).
• U — Uremia: Advanced chronic kidney disease (GFR $<15-20\text{ mL/min}$) impairs excretion of inorganic phosphates, sulfates, and organic anions.
• D — Diabetic Ketoacidosis (DKA): Insulin deficiency promotes unregulated lipolysis and hepatic ketogenesis, accumulating $\beta$-hydroxybutyrate and acetoacetate.
• P — Paraldehyde / Propylene Glycol: Solvent found in IV infusions (e.g., lorazepam, diazepam), metabolized to lactate and pyruvate.
• I — Isoniazid / Iron: Overdose causes mitochondrial toxicity, severe lactic acidosis, and hepatic failure.
• L — Lactic Acidosis: Accumulation of L-lactate ($>4-5\text{ mmol/L}$). Subdivided into:
  • Type A (Tissue Hypoperfusion/Hypoxia): Septic shock, cardiogenic shock, hypovolemia, severe anemia, carbon monoxide poisoning.
  • Type B (Metabolic/Toxic): Metformin toxicity, severe liver disease, hematologic malignancies, thiamine deficiency, hereditary mitochondrial enzyme disorders.
• E — Ethylene Glycol: Ingestion of automotive antifreeze; metabolized to glycolic acid and oxalic acid. Oxalate binds calcium, forming calcium oxalate monohydrate (dumbbell/picket fence shaped) or dihydrate (envelope shaped) crystals in renal tubules, leading to acute tubular necrosis.
• S — Salicylates (Aspirin): Toxic doses directly stimulate the medullary respiratory center (producing an initial respiratory alkalosis) and uncouple oxidative phosphorylation in mitochondria, producing a severe high anion gap metabolic acidosis.

Normal Anion Gap Metabolic Acidosis (NAGMA / Hyperchloremic Acidosis)

Characterized by direct loss of bicarbonate from the body. As $HCO_3^-$ is lost, the kidneys retain chloride ($Cl^-$) in a 1:1 stoichiometric ratio to maintain electroneutrality, resulting in hyperchloremia with a normal anion gap ($8-16\text{ mmol/L}$):

• Gastrointestinal Loss of $HCO_3^-$: Severe diarrhea, enterocutaneous fistulas, drainage of pancreatic or biliary secretions.
• Renal Tubular Acidosis (RTA):
  • Type 1 (Distal RTA): Failure of distal tubular intercalated cells to excrete $H^+$ ions into urine. Urine pH cannot acidify below 5.5 despite systemic acidemia. Leads to nephrolithiasis and nephrocalcinosis.
  • Type 2 (Proximal RTA): Defect in proximal tubular reabsorption of filtered $HCO_3^-$. Urine pH varies; associated with Fanconi syndrome (glucosuria, aminoaciduria, phosphaturia).
  • Type 4 (Hyperkalemic RTA): Mineralocorticoid deficiency or renal resistance to aldosterone. Unlike Types 1 and 2 (which feature hypokalemia), Type 4 characteristically exhibits hyperkalemia.
• Iatrogenic: Rapid, massive intravenous administration of 0.9% NaCl (normal saline). Normal saline contains $154\text{ mmol/L}$ of $Na^+$ and $154\text{ mmol/L}$ of $Cl^-$ (far higher than plasma $Cl^-$ of $100\text{ mmol/L}$), diluting plasma bicarbonate and driving a hyperchloremic acidosis.

Causes of a Low Anion Gap ($<8\text{ mmol/L}$)

A low or negative anion gap is uncommon and should prompt laboratory investigation:

1. Severe Hypoalbuminemia: Albumin is the primary contributor to unmeasured anions in plasma (each $1.0\text{ g/dL}$ drop in serum albumin below $4.0\text{ g/dL}$ reduces the expected anion gap by $\approx 2.5\text{ mmol/L}$): $\text{Corrected AG} = \text{Observed AG} + 2.5 \times (4.0 - \text{Albumin [g/dL]})$
2. Multiple Myeloma (IgG Paraproteinemia): Monoclonal IgG antibodies are positively charged cations at physiological pH, expanding unmeasured cations and artificially suppressing the anion gap.
3. Severe Hypercalcemia, Hypermagnesemia, or Lithium Toxicity: Elevation of unmeasured circulating cations.
4. Severe Bromide or Iodide Intoxication: Bromide ions interfere with chloride ISE membranes, producing spuriously massive overestimation of chloride and yielding an apparent negative anion gap.

---

6. Serum Osmolality and the Osmolal Gap

Osmolality measures the number of osmoles (particles) of solute per kilogram of solvent ($\text{mOsm/kg}$). In the laboratory, serum osmolality is measured using freezing point depression osmometry, based on the physical colligative principle that dissolving one mole of any non-volatile solute into 1 kilogram of water lowers its freezing point by $1.86^\circ\text{C}$ ($K_f = 1.86^\circ\text{C}\cdot\text{kg/mol}$).

Calculated Serum Osmolality

Under normal physiological conditions, sodium and its accompanying anions account for $>90\%$ of plasma osmolality, with glucose and urea nitrogen contributing the remainder. Calculated osmolality is derived using standard conventional units (mg/dL): $\text{Osmolality}_{\text{calc}} = 2[Na^+\text{ mmol/L}] + \frac{\text{Glucose [mg/dL]}}{18} + \frac{\text{BUN [mg/dL]}}{2.8}$ (Note: 18 and 2.8 represent the molecular weights of glucose [$180\text{ g/mol}$] and urea nitrogen [$28\text{ g/mol of } N_2$] divided by 10 to convert mg/dL to mmol/L. If using SI units with glucose and urea in mmol/L, the formula is: $\text{Osmolality} = 2[Na^+] + [\text{Glucose}] + [\text{Urea}]$). Reference interval for measured serum osmolality: $275 - 295\text{ mOsm/kg}$.

The Osmolal Gap

The osmolal gap represents the difference between measured and calculated osmolality: $\text{Osmolal Gap} = \text{Measured Osmolality} - \text{Calculated Osmolality}$

• Normal reference value: $< 10\text{ mOsm/kg}$.
• An elevated osmolal gap ($> 10\text{ mOsm/kg}$) demonstrates the pathological presence of unmeasured, low-molecular-weight exogenous osmotically active substances:
  • Methanol: Wood alcohol; induces both elevated osmolal gap AND elevated anion gap (formate).
  • Ethylene Glycol: Antifreeze; induces elevated osmolal gap AND elevated anion gap (glycolate/oxalate).
  • Isopropanol: Rubbing alcohol; induces an elevated osmolal gap WITHOUT an elevated anion gap because its primary metabolite is acetone (a neutral ketone, not an organic acid).
  • Ethanol: Drinking alcohol; the most common cause of an elevated osmolal gap (each $100\text{ mg/dL}$ of blood alcohol contributes $\approx 22\text{ mOsm/kg}$ to osmolality).
  • Diabetic Ketoacidosis: Can cause mild osmolal gap elevation due to high concentrations of acetone and acetoacetate.

---

7. Divalent Cations: Calcium and Magnesium Dynamics

Calcium ($Ca^{2+}$: 8.6–10.2 mg/dL)

Total serum calcium exists in three distinct physicochemical states:

1. Free / Ionized Calcium ($iCa^{2+}$): Accounts for $\approx 50\%$ of total calcium ($4.6 - 5.3\text{ mg/dL}$ or $1.15 - 1.33\text{ mmol/L}$). This is the only physiologically active fraction, regulating neuromuscular transmission, cardiac contractility, and enzyme activation.
2. Protein-Bound Calcium: Accounts for $\approx 40\%$, primarily bound to albumin (80%) and globulins (20%).
3. Diffusible Complexed Calcium: Accounts for $\approx 10\%$, chelated to organic and inorganic anions including bicarbonate, citrate, phosphate, and lactate.

The Calcium-Albumin Correction

Because $\approx 40\%$ of serum calcium is bound to albumin, significant alterations in serum albumin concentration alter total measured calcium without changing the physiologically active ionized calcium fraction. For every $1.0\text{ g/dL}$ reduction in serum albumin below the normal population mean ($4.0\text{ g/dL}$), total measured calcium decreases by approximately $0.8\text{ mg/dL}$: $\text{Corrected } Ca\text{ [mg/dL]} = \text{Measured Total } Ca\text{ [mg/dL]} + 0.8 \times (4.0 - \text{Albumin [g/dL]})$ Clinical Caveat: In critically ill, acidemic, or septic patients, the correction formula is unreliable, and direct quantification of ionized calcium via ISE on a blood gas analyzer is mandated.

Blood pH and Ionized Calcium

Binding of calcium to albumin is pH-dependent. Plasma proteins carry negative charges that bind $Ca^{2+}$ and $H^+$. In alkalemia (elevated pH), $H^+$ dissociates from albumin carboxyl groups, exposing negative binding sites that bind ionized calcium. Consequently, ionized calcium falls, triggering acute neuromuscular tetany (Chvostek and Trousseau signs) even if total serum calcium is normal. In acidemia (low pH), excess $H^+$ displaces $Ca^{2+}$ from albumin, increasing ionized calcium.

Hormonal Regulation of Calcium and Phosphate

Serum calcium and inorganic phosphate ($PO_4^{3-}$, $2.5-4.5\text{ mg/dL}$) maintain an inverse/reciprocal solubility product relationship in serum ($[Ca] \times [PO_4]$):

Magnesium ($Mg^{2+}$: 1.7–2.2 mg/dL or 0.7–1.0 mmol/L)

Magnesium is the second most abundant intracellular cation. It functions as an indispensable cofactor for $>300$ enzymatic reactions, including all reactions involving ATP cleavage or synthesis, nucleic acid synthesis, and membrane stabilization.

• Hypomagnesemia ($<1.7\text{ mg/dL}$): Caused by chronic alcoholism, malnutrition, loop/thiazide diuretics, aminoglycosides, or prolonged diarrhea. Severe hypomagnesemia impairs parathyroid hormone secretion and induces peripheral end-organ resistance to PTH, resulting in refractory hypocalcemia. Furthermore, magnesium deficiency impairs renal $Na^+/K^+$-ATPase function, causing renal potassium wasting and refractory hypokalemia. Refractory hypokalemia and hypocalcemia cannot be corrected with calcium or potassium supplementation until magnesium is replenished.
• Hypermagnesemia ($>2.2\text{ mg/dL}$): Uncommon, typically seen in acute or chronic renal failure coupled with excessive ingestion of magnesium-containing antacids, laxatives, or therapeutic magnesium sulfate infusions (used in preeclampsia/eclampsia). Clinical features include loss of deep tendon reflexes ($>4-5\text{ mg/dL}$), respiratory depression ($>10\text{ mg/dL}$), and fatal heart block ($>15\text{ mg/dL}$).

---

8. Summary of Reference Intervals and Panic Values